Infection Control Market Is Growing Rapidly With STERIS Plc Completing The Acquisition Of Infection Control Service Provider Cantel Medical Corporation

Infection Control Market


 Infection control and management is the field concerned with preventing health-related infections; a more practical rather than the academic subject matter of epidemiology. Infection prevention and control refers to the practice of preventing healthcare-associated infections. Infection control has become an essential part of the infrastructure healthcare with a wide use of antibiotics, antiseptics, antivirals, and antibacterial. The demand for infection control has risen up significantly over the years with growing burden of chronic diseases such as cancer, diabetes, and cardiovascular diseases. As per the World Health Organization (WHO), the global prevalence of diabetes among adults aged 18 years and above increased from 4.7% in 1980 to 8.5% in 2014. According to the same source, in 2018, around 9.6 million deaths were attributed to cancer, of which 2.09 million cases were lung cancer. According to the WHO, around 17.9 million people die of cardiovascular diseases every year. These factors can stimulate growth of the infection control market in the near future.

Although the majority of population does not realize that, in most hospitals and other healthcare facilities across the country, outbreaks of deadly diseases occur due to a number of different reasons. For instance, healthcare workers are under tremendous pressure to work quickly and efficiently, often without adequate infection control measures in place. As a result, the results of their efforts can be disastrous. Furthermore, most hospitals and healthcare facilities are bound by municipal ordinances that require them to ensure that they maintain a very high level of cleanliness in their facilities. Such laws and regulations are significantly strict in developed regions such as North America and thus, the demand for infection control has increased in the U.S. as well as Canada. The healthcare infrastructure in the aforementioned countries is robust and fairly advanced as compared to emerging economies. Furthermore, the hospitals in these countries are increasingly adopting advanced infection control technologies, to curb the spread of hospital-acquired diseases.

However, there are major concerns regarding the safety of reprocessed instruments, which could impede growth of the infection control market. Besides, there is low awareness regarding infection control in emerging economies, which remains one of the major barriers. When infections do occur in healthcare settings, they can quickly become viral and result in widespread contamination throughout a hospital or other such environment. Such an infection could then spread among other personnel, resulting in even more infections. It may be necessary to implement infection control measures such as a "zero-patient" policy where there are zero visitors to any patient.

Recently, in January 2021, STERIS plc acquired Cantel Medical Corporation, a provider of infection control products, and services.

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)